Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Protein and exercise may boost muscle before dialysis

NCT ID NCT05482243

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a tailored program of protein supplements and exercise can increase muscle protein production in people with advanced chronic kidney disease (CKD) who are not yet on dialysis. Researchers compared these patients to healthy adults to see how their bodies respond. The goal is to find ways to prevent muscle loss and maintain independence before dialysis becomes necessary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Jan 2023

Finished

Dec 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

1. In order to be eligible to participate in this study, a patient with CKD must meet all of the following criteria: * (e)glomerular filtration rate (GFR) \<45 ml/min/1.73m2 * Age: 18 - 80 y * Able to provide written informed consent 2. In order to be eligible to participate in this study, a healthy subject must meet all of the following criteria: * (e)GFR \>60 ml/min/1.73m2 without albuminuria * Age: 18 - 80 y * Able to provide written informed consent 1\. A potential subject with CKD who meets any of the following criteria will be excluded from participation in this study: * Insulin-dependent diabetes mellitus or two or more oral glucose lowering medications * Active inflammatory disease / malignancies * Uncontrolled hypertension (\>160/100mm Hg), unstable angina pectoris, or arrhythmia * Pulmonary disease restricting exercise performance (e.g. COPD) * A history of neuromuscular problems * Cognitive Impairment * Diagnosed GI tract diseases / dysphagia * Allergies to milk proteins / Lactose intolerance * Pregnancy * Hospitalization \<1 months prior to study period * Participation in any structured exercise program * Any medications known to affect protein metabolism (i.e. corticosteroids or prescription strength acne medications). * Use of DOAC, vitamin-K-antagonist, or multiple anticoagulants. * Dialysis treatment or previous kidney transplantation 2\. A potential healthy subject who meets any of the following criteria will be excluded from participation in this study: * Insulin-dependent diabetes mellitus or two or more oral glucose lowering medications * Active inflammatory disease / malignancies * Uncontrolled hypertension (\>160/100mm Hg), unstable angina pectoris, or arrhythmia * Pulmonary disease restricting exercise performance (e.g. COPD) * A history of neuromuscular problems * Cognitive Impairment * Diagnosed GI tract diseases / dysphagia * Allergies to milk proteins / Lactose intolerance * Pregnancy * Hospitalization \<1 months prior to study period * Participation in any structured exercise program * Any medications known to affect protein metabolism (i.e. corticosteroids or prescription strength acne medications). * Use of DOAC, vitamin-K-antagonist, or multiple anticoagulants.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Advanced chronic kidney disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Maastricht University Medical Center+

    Maastricht, Limburg, 6229ER, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.